Viracta Therapeutics OverviewViracta Therapeutics Net Income
Profitability analysis for VIRX.
Quarterly Net Income
-$10.55M
↑ 16.25% YoY
As of Sep 2024
Annual Net Income (TTM)
-$43.29M
↑ 10.76% YoY
Trailing 12 months ending Sep 2024
Average Net Income (Comparison Companies)
Net Income History
Net Income Comparison
Annual Net Income Growth Rate (%)
Loading...
Annual Net Income Growth (Absolute)
Loading...